PharmaShots | Incisive News in 3 Shots

Subscribe Now

BiXAb

Sanofi Licenses Biomunex Pharmaceuticals' BiXAb Technology to Develop Bi- and Multi-Specific Antibodies

Sanofi Licenses Biomunex Pharmaceuticals' BiXAb Technology to Develop Bi- and Multi-Specific Antibodies

January 16, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us